European Commission Approves Lupin’s Biosimilar Ra...
Category : Approval/Launch 24 February 2026Lupin Limited has received approval from the European Commission for its biosimilar ranibizumab, Ran...
Approval Launch
FDA Accepts Dr Reddy’s 351(k) BLA for Proposed Int...
Category : Approval/Launch 24 February 2026Dr. Reddy's Laboratories has announced that the U.S. Food and Drug Administration (FDA) has acce...
Zydus introduces biosimilar Aflibercept 2 mg Anyra...
Category : Approval/Launch 20 February 2026Zydus Lifesciences Ltd., an innovation-led global life sciences company, announced the launch of Any...
Takeda’s Oveporexton Receives FDA Priority Review...
Category : Approval/Launch 12 February 2026Takeda announced that the US FDA has accepted its New Drug Application (NDA) for oveporexton (TAK-86...
Innocan Publishes Placebo-Controlled Study Showing...
Category : Approval/Launch 10 February 2026Innocan Pharma Corporation has published new clinical data in Frontiers in Veterinary Science demons...
Latest Newsletter Post
-
Acurx Pharmaceuticals Launches New..
10 March 2026
-
AbbVie Reports Promising Early Resu..
10 March 2026
-
New Data Strengthens Long-Term Safe..
10 March 2026
-
Insilico Medicine’s AI-Discovered C..
9 March 2026
-
Aisa Pharma Inc. Reports Encouragin..
9 March 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com